We all know that high myopia is associated with higher incidences of retinal detachment, glaucoma and myopic maculopathy1. Instigating early, evidence based myopia control in rapidly progressing myopes gives the best outcomes both pathophysiologically and refractively. However when faced with a low, slower progressing myope, or a patient whom has already progressed is there any point in persisting with myopia …
Podcast summary: Professor Mark Bullimore of the University of Houston, Texas USA, tells us more on the complex topic of 0.01% atropine, including its stability as a compound, and takes us on a short journey through chemistry explaining how current studies are using novel formulations to address this issue. Have you heard of ‘heavy water’? I hadn’t, until now! Mark …
Read MoreMore on 0.01% atropine treatment for myopia management – with Prof Mark Bullimore
Podcast summary: Lyndon and Debbie Jones from the Centre for Ocular Research and Education and University of Waterloo, Canada, highlight the impact that FDA approval for CooperVision MiSight myopia control contact lens has for eye care practice in the US, and across the world. How does MiSight and the FDA approval fit within the whole ecosystem of myopia control? We …
Podcast summary: Professor James Loughman from Technological University Dublin, and the Centre for Eye Research Ireland, challenges us to think differently about low dose atropine. What are we actually getting in the bottle? How should we approach atropine usage in practice? What will future research tell us? The message on 0.01% atropine is complex and perhaps not what you expect. …
Read MoreAtropine 0.01% for myopia management – with Prof James Loughman
Podcast summary: The International Myopia Institute (IMI) white paper reports are a landmark, peer consensus publication authored by over 80 leading academics across the world. Published on 28 February in high ranking journal Investigative Ophthalmology and Visual Science, the seven papers detail Definitions of myopia, genetics, experimental models, interventions for controlling myopia onset and progression, clinical trial standards and instrumentation …
Read MoreIMI definitions report paper with Prof Ian Flitcroft